Posts
August 01 2023
RVL Pharmaceuticals PLC. announced the closing of its Registered Direct offering in the amount of $5,000,000. EG&S acted as counsel to the Placement Agent.
August 01 2023
NRX Pharmaceuticals, Inc. announced the commencement of its At The Market Offering in the amount of $2,000,000. EG&S acted as counsel to the Sales Agent.
August 01 2023
Tivic Health Systems, Inc. announced the closing of its Public Offering in the amount of $1,400,000. EG&S acted as counsel to the Placement Agent.
August 01 2023
Electriq Power, Inc., a provider of intelligent energy storage and management for homes and small businesses, and TLG Acquisition One Corp., a publicly traded special purpose acquisition company, announced the completion of their previously announced merger. The combined company will operate as Electriq Power Holdings, Inc. and its common stock and warrants will start trading on the New York Stock Exchange and NYSE American, respectively, under the ticker symbols “ELIQ” and “ELIQ WS,” respectively. EGS acted as counsel to Electriq Power, Inc.
July 31 2023
Stryve Foods, Inc. announced the commencement of its At The Market Offering in the amount of $5,700,000. EG&S acted as counsel to the Sales Agent.
July 30 2023
Stryve Foods, Inc. announced the commencement of its At The Market Offering in the amount of $5,700,000. EG&S acted as counsel to the Sales Agent.
July 29 2023
RedHill Biopharma Ltd. announced the closing of its Registered Direct offering and Warrant Exercise in the amount of $3,800,000. EG&S acted as counsel to the Placement Agent.
July 28 2023
IMAC Holdings, Inc. announced the closing of its Private Placement Offering in the amount of $4,300,000. EG&S acted as counsel to the Placement Agent.